Rahul Bhargava: Multiple Myeloma – the Poster Child of Innovation
Rahul Bhargava, Director and Head of Hematology, Hematoncology and Stem Cell Transplant at Fortis Health Care, posted on LinkedIn:
”Modern medicine – hope for all
Multiple Myeloma – the Poster Child of Innovation”
Multiple Myeloma truly stands as the poster boy of innovation and progress in modern hematology.
Every passing year brings a new wave of hope -breakthrough drugs, smarter combinations, and longer survival for patients once considered refractory.
We recently witnessed the remarkable impact of one such therapy in a 6th-line refractory patient post Car T cell -a reminder that science, perseverance, and timely access can turn despair into possibility.
We are living in extraordinary times where innovation is rewriting survival curves.
All we need is the means and momentum to ensure every patient benefits.
That’s why we can’t afford relapse -not in science, not in spirit.
God bless the progress, the patients, and the people behind this revolution.
Great work Heme Team
Center of excellence for myeloma and lymphoma FMRI gurugram
Anusha S., Nikhil M Kumar, Yashpal Singh Rawat, Rachit Agrawal, Devyani Surange, Aastha Gupta, Dr. Neha Rastogi Panda.”

Stay updated with Hemostasis Today.
-
Aug 31, 2026, 16:39Shariq Shamim: Are We Going to Start DOAC post TAVI not DAPT?
-
Aug 31, 2026, 16:30Bartosz Hudzik: 5th Universal MI Definition Moves Closer to Biology in Women
-
Aug 31, 2026, 16:13Seema Dawood: Nucleated Red Blood Cells – What They Tell Us on a Peripheral Smear
-
Aug 31, 2026, 16:02Antonio Sorropago: Major Updates in Structural Heart Interventions
-
Aug 31, 2026, 15:44Andrea Boccatonda: Special Issue on Pulmonary Embolism and Venous Thromboembolism
-
Aug 31, 2026, 15:41Adrien Jossart: Acute Thrombotic Storm Following Single Heparin Bolus
-
Aug 31, 2026, 15:36Bernhard Gerber: Myocardial Platelet Activation Linked to Microvascular Obstruction After STEMI
-
Aug 31, 2026, 15:34Higher Fibrinogen γ′ Linked to Increased Risk of Recurrent Arterial Thrombosis – Journal of Thrombosis and Haemostasis
-
Aug 31, 2026, 15:21Ney Carter Borges: Anticoagulation Versus Antiplatelet Therapy After TAVI ESC 26